Disease Info Card

Supranuclear Palsy

Information about Supranuclear Palsy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Supranuclear Palsy

Most recent studies have shown that Supranuclear Palsy shares some biological mechanisms with abnormal-degeneration, alzheimers-disease, atrophy, basal-ganglia-diseases, corticobasal-degeneration, dementia, frontotemporal-dementia, impaired-cognition, lewy-body-disease, movement-disorders, multiple-system-atrophy, nerve-degeneration, neurodegenerative-disorders, neurofibrillary-tangles, ophthalmoplegia, parkinson-disease, pick-disease-of-the-brain, progressive-supranuclear-palsy, secondary-parkinson-disease, tauopathies.

Among the many pathways, these few ones have gauged particular interests from scientists studying Supranuclear Palsy, and have been seen in publications frequently: Aging, Autophagy, Cell Death, Cognition, Dopamine Uptake, Hyperphosphorylation, Hypersensitivity, Innervation, Localization, Locomotion, Micturition, Mrna Splicing, Myelination, Neuroprotection, Pathogenesis, Proteolysis, Reflex, Secretion, Segmentation, Transport

Quite a number of genes have been found to play important roles in Supranuclear Palsy, such as APOE, BPIFA2, CBS, CSF2, GRN, IGFALS, LAMC2, MAPT, MSMB, PSPH, PSPN, REG1A, SLC6A3, SNCA, SOD1, STXBP3, TARDBP, TPO. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.